Keyword [Economic evaluation]
Result: 101 - 120 | Page: 6 of 7 |
| 101. | Economic Evaluation Of Direct-Acting Antivirals In The Treatment Of Chronic Hepatitis C |
| 102. | Safety,Efficacy And Economic Evaluation Of Gefitinib Combined With Aidi Injection In The Treatment Of Non-small Cell Lung Cancer |
| 103. | An economic evaluation of HIV-associated facial lipoatrophy treatments: A cost-utility analysis |
| 104. | Policy modeling and economic evaluation of tuberculosis control |
| 105. | Economic evaluation of vaccination programs: Cost-effectiveness, externalities, and affordability of hepatitis B vaccination |
| 106. | Economic evaluation of renal replacement therapies and immunosuppressants of renal transplantation |
| 107. | Economic evaluation of treating chronic obstructive pulmonary disease: The effects of early initiation of inhaled corticosteroids on exacerbation risks, utilization and costs |
| 108. | Onchocerciasis, lymphatic filariasis, soil transmitted helminthiasis, and schistosomiasis: Integration and economic evaluation of mass drug administration using ivermectin, albendazole, and praziquantel |
| 109. | Quantifying Uncertainty in the Efficacy of Vitamin K on Fractures in Postmenopausal Women: Economic Evaluation, Evidence Synthesis and Bayesian Meta- Analysis |
| 110. | Economic evaluation of 21-gene assay for early stage breast cancer patients from the perspective of the Chinese health care system |
| 111. | An economic evaluation of a patient navigation program for improving cancer screening adherence among elderly African Americans in Baltimore City |
| 112. | Economic evaluation of biological therapy use among patients with Crohn's disease |
| 113. | Economic evaluation of early treatment for patients with primary open-angle glaucoma |
| 114. | Outcome measures in economic evaluations of rheumatoid arthritis |
| 115. | The Economic Evaluation of Manitoba Health Lines in the Management of Congestive Heart Failure |
| 116. | Economics of nosocomial MRSA infection in Europe: Measuring the direct costs of infection, with an economic evaluation of rapid screening on admission to hospital surgical wards |
| 117. | Economic evaluation of cardiac rehabilitation and secondary prevention services |
| 118. | Economic evaluation of vaccination programmes in humans: A methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination |
| 119. | An economic evaluation of clopidogrel in patients with vascular disease |
| 120. | An Health Economic Evaluation For Hypertension Management In Communities |
|
